日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

"There is a life before and after cancer": experiences of resuming life and unmet care needs in stage I and II melanoma survivors

“癌症前后,人生亦有不同”:I期和II期黑色素瘤幸存者重返生活的经历及未被满足的护理需求

Kamminga, N C W; Kievits, J E C; Wakkee, M; Loon, S G W van; Joosen, M C W; Verver, D; Munte, K; Plaisier, P W P; Rietjens, J A C; Nijsten, T E C; Lugtenberg, M

Correction: "There is a life before and after cancer": experiences of resuming life and unmet care needs in stage I and II melanoma survivors

更正:“癌症前后都有生活”:I期和II期黑色素瘤幸存者恢复生活的经历和未满足的护理需求

Kamminga, N C W; Kievits, J E C; Wakkee, M; van Loon, S G W; Joosen, M C W; Verver, D; Munte, K; Plaisier, P W P; Rietjens, J A C; Nijsten, T E C; Lugtenberg, M

Implementation of vacuum-assisted excision as a management option for benign and high-risk breast lesions

将真空辅助切除术作为良性和高风险乳腺病变的一种治疗选择

van de Voort, Elles Mf; Struik, Gerson M; Birnie, Erwin; Sinke, Renata Hja; Verver, Daniëlle; van Streun, Sophie P; Macco, Maura; Verhoef, C; Klem, Taco Mal

Mechanics of CRISPR-Cas12a and engineered variants on λ-DNA

CRISPR-Cas12a及其工程化变体对λ-DNA的作用机制

Paul, Bijoya; Chaubet, Loïc; Verver, Dideke Emma; Montoya, Guillermo

Recurrent tuberculosis in the Netherlands - a 24-year follow-up study, 1993 to 2016

荷兰复发性结核病——一项为期24年的随访研究(1993年至2016年)

Erkens, Connie; Tekeli, Betül; van Soolingen, Dick; Schimmel, Henrieke; Verver, Suzanne

Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse

利用临床病理及基因表达(CP-GEP)模型识别有疾病复发风险的I-II期黑色素瘤患者

Mulder, Evalyn E A P; Johansson, Iva; Grünhagen, Dirk J; Tempel, Dennie; Rentroia-Pacheco, Barbara; Dwarkasing, Jvalini T; Verver, Daniëlle; Mooyaart, Antien L; van der Veldt, Astrid A M; Wakkee, Marlies; Nijsten, Tamar E C; Verhoef, Cornelis; Mattsson, Jan; Ny, Lars; Hollestein, Loes M; Olofsson Bagge, Roger

Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma

组织病理学和免疫学谱在评估 talimogene laherparepvec 治疗对皮肤黑色素瘤患者疗效中的相关性及其与持久疗效的关联

Mulder, Evalyn E A P; Damman, Jeffrey; Verver, Daniëlle; van der Veldt, Astrid A M; Tas, Sam; Khemai-Mehraban, Tamana; Heezen, Kim C; Wouters, Roxane A; Verhoef, Cornelis; Verjans, Georges M G M; Langerak, Anton W; Grünhagen, Dirk J; Mooyaart, Antien L

Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma

验证原发性皮肤黑色素瘤前哨淋巴结转移的临床病理及基因表达谱模型

Mulder, E E A P; Dwarkasing, J T; Tempel, D; van der Spek, A; Bosman, L; Verver, D; Mooyaart, A L; van der Veldt, A A M; Verhoef, C; Nijsten, T E C; Grunhagen, D J; Hollestein, L M

False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC)

接受 talimogene laherparepvec (T-VEC) 治疗的黑色素瘤患者出现 FDG 摄取假阳性

Mulder, Evalyn E A P; Stahlie, Emma H A; Verver, Daniëlle; Lemstra, Clara; Been, Lukas B; Mooyaart, Antien L; Brabander, Tessa; Vegt, Erik; Verburg, Frederik A; van der Veldt, Astrid A M; Verhoef, Cornelis; van Akkooi, Alexander C J; Grünhagen, Dirk J

Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population-based study

免疫疗法和靶向疗法时代不明原发性黑色素瘤的治疗:一项基于荷兰人群的研究

Verver, D; van der Veldt, Aam; van Akkooi, Acj; Verhoef, C; Grünhagen, D J; Louwman, W J